The FDA has granted orphan drug designation (ODD) to LP-284, a next-generation acylfulvene small molecule, for the treatment ...

Inhibrx Biosciences, Inc. stays a Strong Buy with Q2 2026 ozekibart BLA catalyst, 2026 PFS data, and Ewing sarcoma updates.

Kimberley Nix was a 28-year-old medical resident when she was diagnosed with metastatic sarcoma. Today, she continues her studies while sharing her journey on social media Stephanie Sengwe is a pop ...

Ewing sarcoma is a malignant type of bone tumor, meaning it is a form of cancer that spreads. According to a 2024 review, Ewing sarcoma is the second most common primary cancerous bone tumor. It ...

Neoadjuvant treatment evaluation in soft tissue sarcomas (STS): Looking for news in radiologic and pathologic response. Background: Uterine leiomyosarcoma (LMS) is a rare disease and, when recurs or ...

Combination therapy of botensilimab (BOT) plus balstilimab (BAL) was approved Monday as an updated national treatment protocol for patients with certain ovarian cancers and soft tissue sarcomas (STS) ...

A novel intratumoral treatment was administered to the first patient in a phase 3 trial for certain patients with metastatic soft tissue sarcoma. A phase 3 trial for patients with metastatic soft ...

Soft tissue sarcomas rarely metastasize to the heart, with cardiac involvement seen in less than 0.03% of cases. Metastatic heart disease presents diagnostic challenges due to nonspecific symptoms, ...

Add Yahoo as a preferred source to see more of our stories on Google. TikToker Kimberley Nix, who documented her three year journey with metastatic sarcoma, has died at the age of 31. As a final ...

Intensity Therapeutics’ stock has risen nearly 400% after its oncology candidate showed high overall survival (OS) and disease control. In the Phase I/II trial (NCT03058289), INT230-6 showed a disease ...